Uniprot AC	Entrez ID	Gene Name	Disease	Cell Type	PTM Type	State	Position	PMID
O00429	10059	DNM1L DLP1 DRP1	Esophageal cancer		Acetylation	N	M1	
O00429	10059	DNM1L DLP1 DRP1	Sarcoma		Acetylation	N	M1	
O00429	10059	DNM1L DLP1 DRP1	Encephalopathy		Phosphorylation	N	S40	
O00429	10059	DNM1L DLP1 DRP1	Uterine corpus endometrial carcinoma		Phosphorylation	N	S40	
O00429	10059	DNM1L DLP1 DRP1	Uterine corpus endometrial carcinoma		Phosphorylation	N	S44	
O00429	10059	DNM1L DLP1 DRP1	Uterine corpus endometrial carcinoma		Ubiquitination	N	K92	
O00429	10059	DNM1L DLP1 DRP1	Uterine corpus endometrial carcinoma		Ubiquitination	N	K97	
O00429	10059	DNM1L DLP1 DRP1	Uterine corpus endometrial carcinoma		Ubiquitination	N	K99	
O00429	10059	DNM1L DLP1 DRP1	Uterine corpus endometrial carcinoma		Phosphorylation	N	T102	
O00429	10059	DNM1L DLP1 DRP1	Delayed speech and language development		Methylation	N	R108	
O00429	10059	DNM1L DLP1 DRP1	Esophageal adenocarcinoma		Phosphorylation	N	S126	
O00429	10059	DNM1L DLP1 DRP1	Esophageal adenocarcinoma		Ubiquitination	N	K133	
O00429	10059	DNM1L DLP1 DRP1	Renal cell carcinoma		Ubiquitination	N	K133	
O00429	10059	DNM1L DLP1 DRP1	Esophageal adenocarcinoma		Phosphorylation	N	S136	
O00429	10059	DNM1L DLP1 DRP1	Renal cell carcinoma		Phosphorylation	N	S136	
O00429	10059	DNM1L DLP1 DRP1	Bladder urothelial carcinoma		Ubiquitination	N	K160	
O00429	10059	DNM1L DLP1 DRP1	Optic atrophy		Phosphorylation	N	T193	
O00429	10059	DNM1L DLP1 DRP1	Skin cutaneous melanoma		Phosphorylation	N	T193	
O00429	10059	DNM1L DLP1 DRP1	Skin cutaneous melanoma		Phosphorylation	N	S194	
O00429	10059	DNM1L DLP1 DRP1	Skin cutaneous melanoma		Phosphorylation	N	S200	
O00429	10059	DNM1L DLP1 DRP1	Lung squamous cell carcinoma		Ubiquitination	N	K238	
O00429	10059	DNM1L DLP1 DRP1	Head and neck squamous cell carcinoma		Phosphorylation	N	Y266	
O00429	10059	DNM1L DLP1 DRP1	Head and neck squamous cell carcinoma		Ubiquitination	N	K271	
O00429	10059	DNM1L DLP1 DRP1	Head and neck squamous cell carcinoma		Ubiquitination	N	K272	
O00429	10059	DNM1L DLP1 DRP1	Skin cutaneous melanoma		Phosphorylation	N	S330	
O00429	10059	DNM1L DLP1 DRP1	Prostate adenocarcinoma		Phosphorylation	N	Y368	
O00429	10059	DNM1L DLP1 DRP1	Renal cell carcinoma		Phosphorylation	N	Y368	
O00429	10059	DNM1L DLP1 DRP1	Encephalopathy		Phosphorylation	N	T394	
O00429	10059	DNM1L DLP1 DRP1	Encephalopathy		Phosphorylation	N	T400	
O00429	10059	DNM1L DLP1 DRP1	Skin cutaneous melanoma		Phosphorylation	N	Y449	
O00429	10059	DNM1L DLP1 DRP1	Stomach adenocarcinoma		Phosphorylation	N	Y449	
O00429	10059	DNM1L DLP1 DRP1	Head and neck squamous cell carcinoma		Phosphorylation	N	S529	
O00429	10059	DNM1L DLP1 DRP1	Head and neck squamous cell carcinoma		SUMOylation	N	K532	
O00429	10059	DNM1L DLP1 DRP1	Head and neck squamous cell carcinoma		SUMOylation	N	K535	
O00429	10059	DNM1L DLP1 DRP1	Head and neck squamous cell carcinoma		Ubiquitination	N	K535	
O00429	10059	DNM1L DLP1 DRP1	Prostate adenocarcinoma		Phosphorylation	N	S548	
O00429	10059	DNM1L DLP1 DRP1	Renal cell carcinoma		Phosphorylation	N	S548	
O00429	10059	DNM1L DLP1 DRP1	Thyroid carcinoma		Phosphorylation	N	S548	
O00429	10059	DNM1L DLP1 DRP1	Prostate adenocarcinoma		Phosphorylation	N	S552	
O00429	10059	DNM1L DLP1 DRP1	Renal cell carcinoma		Phosphorylation	N	S552	
O00429	10059	DNM1L DLP1 DRP1	Prostate adenocarcinoma		SUMOylation	N	K558	
O00429	10059	DNM1L DLP1 DRP1	Renal cell carcinoma		SUMOylation	N	K558	
O60313	4976	OPA1 KIAA0567	Head and neck squamous cell carcinoma		Phosphorylation	C	S21	
O60313	4976	OPA1 KIAA0567	Head and neck squamous cell carcinoma		Phosphorylation	N	S22	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Phosphorylation	N	S107	
O60313	4976	OPA1 KIAA0567	Head and neck squamous cell carcinoma		Ubiquitination	N	K123	
O60313	4976	OPA1 KIAA0567	Lung squamous cell carcinoma		Ubiquitination	N	K123	
O60313	4976	OPA1 KIAA0567	Head and neck squamous cell carcinoma		Phosphorylation	N	Y132	
O60313	4976	OPA1 KIAA0567	Lung squamous cell carcinoma		Phosphorylation	N	Y132	
O60313	4976	OPA1 KIAA0567	Stomach adenocarcinoma		Ubiquitination	N	K164	
O60313	4976	OPA1 KIAA0567	Bladder urothelial carcinoma		Ubiquitination	N	K214	
O60313	4976	OPA1 KIAA0567	Bladder urothelial carcinoma		Acetylation	N	K228	
O60313	4976	OPA1 KIAA0567	Breast invasive carcinoma		Acetylation	N	K228	
O60313	4976	OPA1 KIAA0567	Renal cell carcinoma		Acetylation	N	K228	
O60313	4976	OPA1 KIAA0567	Bladder urothelial carcinoma		Ubiquitination	N	K228	
O60313	4976	OPA1 KIAA0567	Breast invasive carcinoma		Ubiquitination	N	K228	
O60313	4976	OPA1 KIAA0567	Renal cell carcinoma		Ubiquitination	N	K228	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Phosphorylation	N	Y268	
O60313	4976	OPA1 KIAA0567	Bladder urothelial carcinoma		Phosphorylation	N	S298	
O60313	4976	OPA1 KIAA0567	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Phosphorylation	N	S298	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Phosphorylation	N	S298	
O60313	4976	OPA1 KIAA0567	Bladder urothelial carcinoma		Ubiquitination	N	K301	
O60313	4976	OPA1 KIAA0567	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Ubiquitination	N	K301	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Ubiquitination	N	K301	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Phosphorylation	N	T302	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Acetylation	N	K328	
O60313	4976	OPA1 KIAA0567	Lung adenocarcinoma		Phosphorylation	N	S344	
O60313	4976	OPA1 KIAA0567	Lung adenocarcinoma		Phosphorylation	N	S345	
O60313	4976	OPA1 KIAA0567	Lung adenocarcinoma		Phosphorylation	N	T351	
O60313	4976	OPA1 KIAA0567	Dominant optic atrophy plus syndrome		Ubiquitination	N	K352	
O60313	4976	OPA1 KIAA0567	Lung adenocarcinoma		Ubiquitination	N	K352	
O60313	4976	OPA1 KIAA0567	Behr syndrome		Phosphorylation	N	S383	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Phosphorylation	N	S383	
O60313	4976	OPA1 KIAA0567	Behr syndrome		Ubiquitination	N	K387	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Ubiquitination	N	K387	
O60313	4976	OPA1 KIAA0567	Behr syndrome		Phosphorylation	N	T405	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Phosphorylation	N	T405	
O60313	4976	OPA1 KIAA0567	Dominant optic atrophy plus syndrome		Phosphorylation	N	S440	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Phosphorylation	N	S440	
O60313	4976	OPA1 KIAA0567	Lung adenocarcinoma		Ubiquitination	N	K474	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Ubiquitination	N	K474	
O60313	4976	OPA1 KIAA0567	Lung adenocarcinoma		Phosphorylation	C	S478	
O60313	4976	OPA1 KIAA0567	Behr syndrome		Ubiquitination	N	K489	
O60313	4976	OPA1 KIAA0567	Hepatocellular carcinoma		Ubiquitination	N	K489	
O60313	4976	OPA1 KIAA0567	Retinal dystrophy		Ubiquitination	N	K489	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Phosphorylation	N	Y498	
O60313	4976	OPA1 KIAA0567	Mitochondrial DNA depletion syndrome		Ubiquitination	N	K530	
O60313	4976	OPA1 KIAA0567	Retinal dystrophy		Ubiquitination	N	K530	
O60313	4976	OPA1 KIAA0567	Mitochondrial DNA depletion syndrome		Phosphorylation	N	T531	
O60313	4976	OPA1 KIAA0567	Mitochondrial DNA depletion syndrome		Phosphorylation	N	S532	
O60313	4976	OPA1 KIAA0567	Mitochondrial DNA depletion syndrome		Ubiquitination	N	K535	
O60313	4976	OPA1 KIAA0567	Retinal dystrophy		Ubiquitination	N	K535	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Ubiquitination	N	K568	
O60313	4976	OPA1 KIAA0567	Dominant optic atrophy plus syndrome		Acetylation	N	K579	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Acetylation	N	K579	
O60313	4976	OPA1 KIAA0567	Dominant optic atrophy plus syndrome		Phosphorylation	N	Y582	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Acetylation	N	K596	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Ubiquitination	N	K598	
O60313	4976	OPA1 KIAA0567	Pancreatic adenocarcinoma		Ubiquitination	N	K598	
O60313	4976	OPA1 KIAA0567	Kidney renal clear cell carcinoma		Phosphorylation	C	S607	
O60313	4976	OPA1 KIAA0567	Kidney renal clear cell carcinoma		Phosphorylation	N	T612	
O60313	4976	OPA1 KIAA0567	Bladder urothelial carcinoma		Ubiquitination	N	K663	
O60313	4976	OPA1 KIAA0567	Bladder urothelial carcinoma		Ubiquitination	N	K699	
O60313	4976	OPA1 KIAA0567	Breast invasive carcinoma		Ubiquitination	N	K699	
O60313	4976	OPA1 KIAA0567	Pancreatic adenocarcinoma		Phosphorylation	N	S708	
O60313	4976	OPA1 KIAA0567	Lung adenocarcinoma		Ubiquitination	N	K713	
O60313	4976	OPA1 KIAA0567	Pancreatic adenocarcinoma		Ubiquitination	N	K713	
O60313	4976	OPA1 KIAA0567	Hepatocellular carcinoma		Methylation	N	R733	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Acetylation	N	K772	
O60313	4976	OPA1 KIAA0567	Adrenocortical carcinoma		Phosphorylation	N	Y808	
O60313	4976	OPA1 KIAA0567	Hepatocellular carcinoma		Phosphorylation	N	Y808	
O60313	4976	OPA1 KIAA0567	Bladder urothelial carcinoma		Methylation	N	R824	
O60313	4976	OPA1 KIAA0567	Prostate adenocarcinoma		Methylation	N	R824	
O60313	4976	OPA1 KIAA0567	Bladder urothelial carcinoma		Phosphorylation	N	S831	
O60313	4976	OPA1 KIAA0567	Colon adenocarcinoma		Phosphorylation	N	S831	
O60313	4976	OPA1 KIAA0567	Colon adenocarcinoma		Acetylation	N	K834	
O60313	4976	OPA1 KIAA0567	Colon adenocarcinoma		Ubiquitination	N	K834	
O60313	4976	OPA1 KIAA0567	Dominant optic atrophy plus syndrome		Ubiquitination	N	K911	
O60313	4976	OPA1 KIAA0567	Head and neck squamous cell carcinoma		Ubiquitination	N	K911	
O60313	4976	OPA1 KIAA0567	Bladder urothelial carcinoma		Ubiquitination	N	K923	
O60313	4976	OPA1 KIAA0567	Lung adenocarcinoma		Ubiquitination	N	K923	
O60313	4976	OPA1 KIAA0567	Uterine corpus endometrial carcinoma		Ubiquitination	N	K923	
O60313	4976	OPA1 KIAA0567	Uterus adenocarcinoma		Ubiquitination	N	K923	
O60313	4976	OPA1 KIAA0567	Bladder urothelial carcinoma		Acetylation	N	K926	
O60313	4976	OPA1 KIAA0567	Lung adenocarcinoma		Acetylation	N	K926	
O60313	4976	OPA1 KIAA0567	Uterine corpus endometrial carcinoma		Acetylation	N	K926	
O60313	4976	OPA1 KIAA0567	Uterus adenocarcinoma		Acetylation	N	K926	
O60313	4976	OPA1 KIAA0567	Bladder urothelial carcinoma		Phosphorylation	N	T929	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Phosphorylation	N	T929	
O60313	4976	OPA1 KIAA0567	Uterine corpus endometrial carcinoma		Phosphorylation	N	T929	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Acetylation	N	K931	
O60313	4976	OPA1 KIAA0567	Uterine corpus endometrial carcinoma		Acetylation	N	K931	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Ubiquitination	N	K940	
O60313	4976	OPA1 KIAA0567	Optic atrophy		Ubiquitination	N	K948	
Q04837	6742	SSBP1 SSBP	Ovarian cancer		Ubiquitination	N	K51	
Q04837	6742	SSBP1 SSBP	Lung squamous cell carcinoma		Phosphorylation	N	S67	
Q04837	6742	SSBP1 SSBP	Optic atrophy		Phosphorylation	N	S67	
Q04837	6742	SSBP1 SSBP	Hepatocellular carcinoma		Phosphorylation	N	S70	
Q04837	6742	SSBP1 SSBP	Lung squamous cell carcinoma		Phosphorylation	N	S70	
Q04837	6742	SSBP1 SSBP	Hepatocellular carcinoma		Phosphorylation	N	Y73	
Q04837	6742	SSBP1 SSBP	Lung squamous cell carcinoma		Phosphorylation	N	Y73	
Q04837	6742	SSBP1 SSBP	Stomach adenocarcinoma		Phosphorylation	N	Y73	
Q04837	6742	SSBP1 SSBP	Hepatocellular carcinoma		Phosphorylation	N	S79	
Q04837	6742	SSBP1 SSBP	Lung squamous cell carcinoma		Phosphorylation	N	S79	
Q04837	6742	SSBP1 SSBP	Stomach adenocarcinoma		Phosphorylation	N	S79	
Q04837	6742	SSBP1 SSBP	Stomach cancer		Phosphorylation	N	S79	
Q04837	6742	SSBP1 SSBP	Hepatocellular carcinoma		Ubiquitination	N	K81	
Q04837	6742	SSBP1 SSBP	Lung squamous cell carcinoma		Ubiquitination	N	K81	
Q04837	6742	SSBP1 SSBP	Stomach adenocarcinoma		Ubiquitination	N	K81	
Q04837	6742	SSBP1 SSBP	Skin cutaneous melanoma		Phosphorylation	N	S88	
Q04837	6742	SSBP1 SSBP	Skin cutaneous melanoma		Phosphorylation	N	Y99	
Q04837	6742	SSBP1 SSBP	Skin cutaneous melanoma		Phosphorylation	N	Y101	
Q04837	6742	SSBP1 SSBP	Optic atrophy		Acetylation	N	K103	
Q04837	6742	SSBP1 SSBP	Optic atrophy		Phosphorylation	N	Y109	
Q04837	6742	SSBP1 SSBP	Optic atrophy		Succinylation	N	K113	
Q04837	6742	SSBP1 SSBP	Head and neck squamous cell carcinoma		Phosphorylation	N	Y119	
Q04837	6742	SSBP1 SSBP	Head and neck squamous cell carcinoma		Ubiquitination	N	K122	
Q04837	6742	SSBP1 SSBP	Optic atrophy		Ubiquitination	N	K145	
Q99798	50	ACO2	Skin cutaneous melanoma		Acetylation	N	K50	
Q99798	50	ACO2	Optic atrophy		Phosphorylation	N	Y71	
Q99798	50	ACO2	Optic atrophy		Phosphorylation	N	S79	
Q99798	50	ACO2	Infantile cerebellar-retinal degeneration		Phosphorylation	N	S112	
Q99798	50	ACO2	Infantile cerebellar-retinal degeneration		Phosphorylation	N	S113	
Q99798	50	ACO2	Stomach adenocarcinoma		Acetylation	N	K144	
Q99798	50	ACO2	Stomach adenocarcinoma		Ubiquitination	N	K144	
Q99798	50	ACO2	Liver cancer		Acetylation	N	K233	
Q99798	50	ACO2	Cholangiocarcinoma		Phosphorylation	N	S242	
Q99798	50	ACO2	Cholangiocarcinoma		Phosphorylation	N	S243	
Q99798	50	ACO2	Cholangiocarcinoma		Ubiquitination	N	K245	
Q99798	50	ACO2	Infantile cerebellar-retinal degeneration		Acetylation	N	K258	
Q99798	50	ACO2	Bladder urothelial carcinoma		Ubiquitination	N	K309	
Q99798	50	ACO2	Bladder urothelial carcinoma		Phosphorylation	N	T310	
Q99798	50	ACO2	Bladder urothelial carcinoma		Acetylation	N	K370	
Q99798	50	ACO2	Bladder urothelial carcinoma		Ubiquitination	N	K370	
Q99798	50	ACO2	Bladder urothelial carcinoma		Ubiquitination	N	K401	
Q99798	50	ACO2	Head and neck squamous cell carcinoma		Ubiquitination	N	K401	
Q99798	50	ACO2	Inborn genetic diseases		Ubiquitination	N	K401	
Q99798	50	ACO2	Uterine corpus endometrial carcinoma		Methylation	N	R474	
Q99798	50	ACO2	Hepatocellular carcinoma		Phosphorylation	N	Y513	
Q99798	50	ACO2	Hepatocellular carcinoma		Phosphorylation	N	T515	
Q99798	50	ACO2	Hepatocellular carcinoma		Acetylation	N	K520	
Q99798	50	ACO2	Hepatocellular carcinoma		Ubiquitination	N	K520	
Q99798	50	ACO2	Inborn genetic diseases		Acetylation	N	K573	
Q99798	50	ACO2	Inborn genetic diseases		Ubiquitination	N	K573	
Q99798	50	ACO2	Head and neck squamous cell carcinoma		Phosphorylation	N	T646	
Q99798	50	ACO2	Mesothelioma		Phosphorylation	N	T646	
Q99798	50	ACO2	Optic atrophy		Phosphorylation	N	Y665	
Q99798	50	ACO2	Bladder urothelial carcinoma		Methylation	N	R679	
Q99798	50	ACO2	Skin cutaneous melanoma		Acetylation	N	K689	
Q99798	50	ACO2	Skin cutaneous melanoma		Ubiquitination	N	K689	
Q99798	50	ACO2	Breast cancer		Acetylation	N	K700	
Q99798	50	ACO2	Breast cancer		Ubiquitination	N	K701	
Q99798	50	ACO2	Skin cutaneous melanoma		Ubiquitination	N	K701	
Q99798	50	ACO2	Breast invasive carcinoma		Ubiquitination	N	K723	
Q99798	50	ACO2	Breast invasive carcinoma		Acetylation	N	K730	
Q99798	50	ACO2	Breast invasive carcinoma		Ubiquitination	N	K730	
Q99798	50	ACO2	Infantile cerebellar-retinal degeneration		Succinylation	N	K736	
Q99798	50	ACO2	Infantile cerebellar-retinal degeneration		Succinylation	N	K739	
Q99798	50	ACO2	Lung adenocarcinoma		Acetylation	N	K743	
Q99798	50	ACO2	Uterine corpus endometrial carcinoma		Acetylation	N	K743	
Q9Y4W6	10939	AFG3L2	Uterine corpus endometrial carcinoma		Acetylation	N	K100	
Q9Y4W6	10939	AFG3L2	Hepatocellular carcinoma		Ubiquitination	N	K173	
Q9Y4W6	10939	AFG3L2	Kidney renal papillary cell carcinoma		Ubiquitination	N	K173	
Q9Y4W6	10939	AFG3L2	Pancreatic cancer		Ubiquitination	N	K173	
Q9Y4W6	10939	AFG3L2	Hepatocellular carcinoma		Phosphorylation	N	Y179	
Q9Y4W6	10939	AFG3L2	Pancreatic cancer		Phosphorylation	N	Y179	
Q9Y4W6	10939	AFG3L2	Hepatocellular carcinoma		Ubiquitination	N	K182	
Q9Y4W6	10939	AFG3L2	Pancreatic cancer		Ubiquitination	N	K182	
Q9Y4W6	10939	AFG3L2	Spastic ataxia		Acetylation	N	K300	
Q9Y4W6	10939	AFG3L2	Spastic ataxia		Ubiquitination	N	K300	
Q9Y4W6	10939	AFG3L2	Spastic ataxia		Acetylation	N	K306	
Q9Y4W6	10939	AFG3L2	Spastic ataxia		Acetylation	N	K308	
Q9Y4W6	10939	AFG3L2	Glioblastoma multiforme		Ubiquitination	N	K342	
Q9Y4W6	10939	AFG3L2	Optic atrophy		Ubiquitination	N	K342	
Q9Y4W6	10939	AFG3L2	Dystonia		Phosphorylation	N	T352	
Q9Y4W6	10939	AFG3L2	Glioblastoma multiforme		Phosphorylation	N	T352	
Q9Y4W6	10939	AFG3L2	Dystonia		Ubiquitination	N	K354	
Q9Y4W6	10939	AFG3L2	Glioblastoma multiforme		Ubiquitination	N	K354	
Q9Y4W6	10939	AFG3L2	Hepatocellular carcinoma		Ubiquitination	N	K508	
Q9Y4W6	10939	AFG3L2	Pancreatic cancer		Ubiquitination	N	K508	
Q9Y4W6	10939	AFG3L2	Spinocerebellar ataxia		Ubiquitination	N	K508	
Q9Y4W6	10939	AFG3L2	Skin cutaneous melanoma		Acetylation	N	K543	
Q9Y4W6	10939	AFG3L2	Skin cutaneous melanoma		Ubiquitination	N	K543	
Q9Y4W6	10939	AFG3L2	Uterine corpus endometrial carcinoma		Ubiquitination	N	K558	
Q9Y4W6	10939	AFG3L2	Spastic ataxia		Acetylation	N	K611	
Q9Y4W6	10939	AFG3L2	Pancreatic adenocarcinoma		Ubiquitination	N	K611	
Q9Y4W6	10939	AFG3L2	Spastic ataxia		Ubiquitination	N	K611	
Q9Y4W6	10939	AFG3L2	Spastic ataxia		Phosphorylation	N	Y614	
Q9Y4W6	10939	AFG3L2	Spastic ataxia		Succinylation	N	K618	
Q9Y4W6	10939	AFG3L2	Spinocerebellar ataxia		Succinylation	N	K618	
Q9Y4W6	10939	AFG3L2	Spastic ataxia		Ubiquitination	N	K618	
Q9Y4W6	10939	AFG3L2	Pancreatic cancer		Methylation	N	R624	
Q9Y4W6	10939	AFG3L2	Spastic ataxia		Methylation	N	R624	
Q9Y4W6	10939	AFG3L2	Pancreatic cancer		Phosphorylation	N	S634	
Q9Y4W6	10939	AFG3L2	Spinocerebellar ataxia		Phosphorylation	N	Y689	
Q9Y4W6	10939	AFG3L2	Skin cutaneous melanoma		Phosphorylation	N	T763	
Q9Y4W6	10939	AFG3L2	Skin cutaneous melanoma		Phosphorylation	N	S765	
Q9Y4W6	10939	AFG3L2	Spinocerebellar ataxia		Phosphorylation	N	S765	
O00429	10059	DNM1L DLP1 DRP1	Oral cancer	tumor tissue	Serine phosphorylation	U	S616	36779631
Q99798	50	ACO2	Prostate cancer	PCa tissues	Deacetylation	D	K258	33115805
O00429	10059	DNM1L DLP1 DRP1	Alzheimer's disease		Serine phosphorylation	U	S40	25192600
O00429	10059	DNM1L DLP1 DRP1	Alzheimer's disease		Serine phosphorylation	U	S44	25192600
O00429	10059	DNM1L DLP1 DRP1	Huntington's disease		Serine phosphorylation	P	S616	29397067
O00429	10059	DNM1L DLP1 DRP1	Heart failure		Serine phosphorylation	U	S616	27739424
O00429	10059	DNM1L DLP1 DRP1	Pancreatic cancer		Serine phosphorylation	U	S616	25658205
O00429	10059	DNM1L DLP1 DRP1	Parkinson's disease		Threonine phosphorylation	U	T595	23813973
O00429	10059	DNM1L DLP1 DRP1	Alzheimer's disease		Serine phosphorylation	U	S616	37174687
O00429	10059	DNM1L DLP1 DRP1	Kidney cancer		Serine phosphorylation	U	S616	35927303
O00429	10059	DNM1L DLP1 DRP1	Nasopharyngeal carcinoma		Serine phosphorylation	U	S616	32433544
O00429	10059	DNM1L DLP1 DRP1	Parkinson's disease		Serine phosphorylation	U	S616	31308800
O00429	10059	DNM1L DLP1 DRP1	Pulmonary hypertension		Serine phosphorylation	U	S616	37442283
O00429	10059	DNM1L DLP1 DRP1	Nasopharyngeal carcinoma		Serine phosphorylation	D	S637	32433544
O00429	10059	DNM1L DLP1 DRP1	Glioblastoma multiforme		Serine phosphorylation	U	S637	35697672
